Susquehanna International Group, LLP Atea Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$3.31 - $4.04 $84,074 - $102,616	-25,400 Reduced 26.91%	69,000 $228,000
Q1 2024 May 07, 2024	BUY	$3.09 - $4.56 $236,385 - $348,839	76,500 Added 427.37%	94,400 $381,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $22,120 - $26,465	7,900 Added 79.0%	17,900 $54,000
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $30,000 - $37,900	10,000 New	10,000 $30,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.17 $4,350 - $6,170	-1,000 Reduced 0.18%	569,400 $2.74 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $460,062 - $736,601	83,800 Added 17.22%	570,400 $3.25 Million
Q2 2022 Aug 15, 2022	BUY	$5.33 - $8.18 $1.87 Million - $2.87 Million	351,200 Added 259.38%	486,600 $3.46 Million
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $957,550 - $1.6 Million	-174,100 Reduced 56.25%	135,400 $978,000
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $1.84 Million - $10.7 Million	239,400 Added 341.51%	309,500 $2.77 Million
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $533,250 - $876,500	-25,000 Reduced 26.29%	70,100 $2.46 Million
Q2 2021 Aug 11, 2021	BUY	$19.22 - $59.08 $1.34 Million - $4.12 Million	69,700 Added 274.41%	95,100 $2.04 Million
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $1.05 Million - $2.25 Million	25,400 New	25,400 $1.57 Million

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.